Clinical Trials in Manchester, UK

Clinical Trials in Manchester

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Site city

All 12 cities

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Recruiting

Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Efanesoctocog Alfa

NCT06940830Hemophilia A

Swedish Orphan Biovitrum

Phase 4

250

Birmingham, Cardiff, London, Manchester

2025-05-21

Recruiting

A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B

NCT05611801Hemophilia A, Hemophilia B

Pfizer

Phase 3

100

Newcastle upon Tyne, Birmingham, London, Manchester

2022-12-09

Active, closed

Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"

NCT03588299Hemophilia A

Bayer

Phase 1/2

Manchester

2018-11-07

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-uk/city/manchester

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →